Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Chordate Medical’s migraine treatment gets attention at congress

Recently, medtech company Chordate Medical participated in the prominent pain congress Deutsche Schmerzkongress in Mannheim, Germany. During the event, they experienced an increased interest in their migraine treatment Ozilia Migraine. This positive reception is expected to strengthen the company’s ongoing marketing activities in Germany, where they previously also conducted a successful patient study. To find out more about the market introduction in Germany and the highlights from the congress, BioStock contacted the company’s CEO Anders Weilandt.Read the full article at biostock.se:

TOMRA: Mandatory notification of trade

TOMRA's CEO Tove Andersen has today bought 5,550 shares in TOMRA Systems ASA at a price of NOK 85.50 per share. After the transaction, Tove Andersen holds 29,479 shares in TOMRA Systems ASA. Further disclosure details can be found in the attached form. Asker, 23 October 2023 TOMRA Systems ASA For further information, please contact: Daniel Sundahl, Head of Investor Relations, Tel: +47 91 36 18 99 This information is considered to be inside information pursuant to the EU Market Abuse Regulation (EU) No 596/2014 and is subject to the disclosure requirements pursuant to Section

Eevia Health Plc receives a 1 mSEK/94 kEUR sales order for a Bilberry extract product

Eevia Health Plc, (”Eevia” or ”The Company”), has received a 94 kEUR sales order from a European nutraceutical brand owner.The customer is a European brand owner headquartered in Sweden. The customer develops and markets effective herbal dietary supplements, as well as cosmetics in over 50.000 pharmacies, health food shops, and other retail outlets across 36 countries, including China and USA. The sales value to Eevia of this new order is 94 kEUR for Feno-Myrtillus® 1, which is a so-called 5:1 Extract. The product is a Bilberry extract standardized for anthocyanins and is a repeat order.

Wärtsilä Decarbonisation Modelling agreement supports Raízen’s commitment to reducing marine sector’s GHG emissions

Wärtsilä Corporation, Trade press release, 23 October 2023 at 10:00 AM EESTTechnology group Wärtsilä has signed a strategic partnership agreement for Decarbonisation Modelling  with Raízen, a major Brazilian energy company. The agreement focuses on both newbuilding and existing operation upgrade plans. Its aim is to build and implement a fleet-wide decarbonisation plan with a particular interest in the future marine introduction of ethanol as a marine fuel. Wärtsilä, under its fleet decarbonisation programme, has a strong track record in bringing new

Svenska Aerogel sales update: “Intensified focus on Transport and one more customer introducing product with Quartzene[®]”

Svenska Aerogel is intensifying its focus on the Transport industry – this is stated by CEO Tor Einar Norbakk as he gives a new sales update. The company is currently engaged in several ongoing customer projects related to battery safety for electric vehicles, and this is reflected in Svenska Aerogel’s customer segmentation strategy moving forward. Tor Einar Norbakk also provides updates on key customers, including one that has introduced a product incorporating Quartzene[®] and is preparing for launch.Svenska Aerogel has decided to focus on three primary customer segments going forward:

BioStock: Spago Nanomedical's promising cancer therapy approved for phase I/IIa

Spago Nanomedical has achieved a significant milestone in its cancer therapy development journey. The company's drug candidate, 177Lu-SN201, has received approval to initiate the clinical phase I/IIa study, Tumorad-01, in Australia. To fully appreciate this endeavour, BioStock reached out to Spago’s CEO Mats Hansen.Read the interview with Mats Hansen at biostock.se: Spago Nanomedical's promising cancer therapy approved for phase I/IIa - BioStock This is a press release from BioStock -

Nomination Committee of Medivir appointed

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the nomination committee now has been appointed ahead of the Annual General Meeting in May 2024.According to an AGM resolution, the Nomination Committee 2023-2024 should consist of representatives of at least the three largest shareholders at the end of the third quarter of 2023 and the Chairman of the Board. Work on composing the Nomination Committee is now completed, and this year’s Nomination Committee consists of: Karl Tobieson, appointed by Linc ABRichard Torgerson, appointed by Nordea Investment

Michigan Medicine harnesses the power of Sectra's digital pathology solution to enhance patient care and foster collaboration among physicians

Linköping, Sweden and Shelton, CT – October 23, 2023 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) announces that the US health and academic center Michigan Medicine is expanding its usage of Sectra’s enterprise imaging solution by including Sectra's module for digital pathology. This will enable their pathologists to review and collaborate around cases, ultimately improving cancer diagnostics in the region.Digital pathology leads to numerous advantages for hospitals, pathologists, and patients. With Sectra’s digital pathology

Circio Holding ASA - Notifation of shareholding

Pursuant to Section 4-2 of the Norwegian Securities Trading Act and the Securities Trading Act Regulations, we hereby disclose the following information on behalf of Atlas Special Opportunities, LLC. Atlas Special Opportunities, LLC ("Atlas") has on 20 October 2023 sold 123 738 shares in Circio Holding ASA. Atlas holds 274,457 shares in Circio, corresponding to 3.83% of the share capital and voting rights in Circio Holding ASA. This information is subject to the disclosure requirements pursuant to section 4 -3 of the Norwegian Securities Trading Act.

Buybacks of shares in ITAB during week 42 2023

During the period between 16 and 20 October 2023, ITAB Shop Concept AB (publ) (”ITAB”) (LEI-code: 2138001H6FCSZBP26351) has repurchased in total 38,417 own ordinary shares (ISIN: SE0015962097) as part of the share buyback program initiated by the Board of Directors in order to optimise the capital structure.The share buybacks form part of the share buyback program in a maximum amount of MSEK 50 that ITAB announced on 28 September 2023. The share buyback program, which runs from 29 September 2023 until 14 May 2024, is being carried out in accordance with the EU Market Abuse Regulation (“MAR”)

Epiroc AB’s Nomination Committee for the Annual General Meeting 2024

Stockholm, Sweden: According to the Instruction for the Nomination Committee adopted by the Annual General Meeting of Epiroc AB, the Nomination Committee should consist of representatives for the four shareholders, directly registered or ownership grouped, controlling the largest number of votes in Epiroc AB that desire to appoint a member. In addition thereto, the Chairman of the Board of Directors shall be a member.The following persons will form the Nomination Committee for the Annual General Meeting 2024. Petra Hedengran - Investor AB (Chair)Joachim Spetz - Swedbank Robur funds

Freetrailer reaches one million rentals

For the first time in the company's history, Freetrailer Group A/S has passed one million rentals during the past 12 months. The record is mainly driven by significantly more locations with the company's partners and the roll-out of 1,275 new units during the period.Freetrailer Group A/S has set a new record in the number of rentals. Over the past 12 months, the use of the company's trailers and electric cargo bikes has reached one million, which corresponds to a continuous growth in the number of rentals of 22% compared to the previous 12 months.   Over the past year, the number of

Wulff Group Plc’s Interim Report for January 1 – September 30, 2023

INTERIM REPORT | OCTOBER 23, 2023 AT 9.30 A.M. This is a summary of Wulff Group Plc’s Interim Report January 1–September 30, 2023. The complete report is attached to this stock exchange release as a pdf-file. The report is also available at the website www.wulff.fi. The third quarter fell short of expectations – operational programme will improve profitability 1.7.–30.9.2023 BRIEFLY · Net sales totalled EUR 21.2 million (24.0), decreased by 11.6% · EBITDA was EUR 0.8 million (1.7) and comparable EBITDA was EUR 1.1 million (1.7) · Operating profit (EBIT) was EUR 0.3

Catena Media announces share buybacks executed from 16 to 20 October 2023

Catena Media plc (LEI code: 549300609A73DL5C5Z86) repurchased 75,000 of its own ordinary shares (ISIN code: MT0001000109) from 16 to 20 October 2023 as part of its share buyback programme. The buyback programme was authorised by shareholders at an extraordinary general meeting on 12 July 2023 and initiated and announced by the board of directors on 17 July 2023. The programme is being carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). Its purpose is to deliver

Encouraging preliminary data from Lytix Biopharma’s ATLAS-IT-05 study presented at ESMO 2023

Oslo, 23 October 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, announces that Dr Stephane Dalle, the top recruiting investigator of the ATLAS-IT-05 study, will give a poster presentation today at the ESMO 2023 Congress.ATLAS-IT-05 is a Phase II open label clinical trial with LTX-315 in combination with Keytruda® (pembrolizumab) in stage III-IV melanoma patients refractory to treatment with PD-1 / PD-L1 inhibitors.   The poster presents early preliminary clinical data from 20 patients (14 patients for efficacy)

Bulten AB nomination committee for 2024 AGM appointed

The Bulten Annual General Meeting will be held in Gothenburg, Sweden on Thursday April 25, 2024. Nomination committee members for the meeting have now been appointed.The nomination committee shall, according to the AGM’s decision, consist of four members: a representative for each of the three major shareholders on the last banking day in September who wish to appoint a member to the nomination committee, and the Chairman of the Board. The three major shareholders refer to those registered and ownership-grouped by Euroclear Sweden AB as of the last banking day in September. If any of the

AFRY awarded owner’s engineering services for a new waste-to-energy project in Malaysia

Worldwide PMC Sdn. Bhd. (WPMC) has awarded AFRY a contract to provide owner’s engineering services for a waste-to-energy project in Kuala Selangor, Malaysia, that will enable more efficient and sustainable municipal waste management.State-of-the-art waste-to-energy (WtE) facilities are an essential component for accelerating the transition to a sustainable future, as they are designed to recover the value of the waste that remains after reusing and recycling, and convert it into energy. The new plant in Malaysia will significantly reduce the amount of waste going to landfills and

Concentric AB wins first important order for next generation Electro Hydraulic Steering (EHS) with leading electric bus OEM in Europe

Concentric AB is proud to announce the win of a significant order of our next-generation Electro Hydraulic Steering (EHS) pump from a leading European electric bus OEM. This order is worth 7 MSEK and will be supplied from Q4 this year, into Q1 of 2024. Based on our strategic relationship with the customer, we are confident that this order will be the foundation for a long-term supply agreement. The new generation of EHS units are fitted with Concentric’s state of the art Internal Gear Pump (IGP), which is optimised to meet low noise steering system requirements, in one compact design.

Getinge Interim Report July - September 2023: Higher sales, gradually strengthened margins and stable cash flows

“Getinge’s sales rose organically by 5.7% in the quarter,” says Mattias Perjos, President & CEO at Getinge. “Most of the operations in Acute Care Therapies performed positively. Sales in Life Science were unchanged and Surgical Workflows grew in all product categories and regions. The order intake declined organically by a total of 1.9% in the quarter, which was exclusively linked to Acute Care Therapies.”The Group’s margins and cash flow were positively impacted sequentially by higher deliveries of consumables, mainly in Cardiac Assist. However, continuing low demand in products for the

Interim report January - September 2023

Good order intake Quarter 3, 2023   · Orders received amounted to SEK 1,488m (1,294), equivalent to currency neutral growth of 11.0 percent compared with the same period last year. · Net sales amounted to SEK 1,574m (1,398), equivalent to currency neutral growth of 7.7 percent compared with the same period last year. · Adjusted EBITA was SEK 175.4m (165.3), giving an adjusted EBITA margin of 11.1 percent (11.8). · Operating profit amounted to SEK 148.0m (138.0), corresponding to an operating margin of 9.4 percent (9.9). · Net profit was SEK 85.4m (92.6). · Earnings

Nitro Games Oyj: Interim Report January – September 2023

THE INTERIM PERIOD JANUARY – SEPTEMBER 2023 · Revenues (Jan – Sep) 5,946.9 KEUR (4,935.0 KEUR in the corresponding period 2022). · EBITDA: -2,502.8 KEUR (-2,444.4 KEUR). · EBIT: -3,377.6 KEUR (-3,051.9 KEUR). · Net result: -3,585.5 KEUR (-3,094.1 KEUR). · Earnings per share (EPS) -0.24 (-0.24). · Cash and cash equivalents: 1,809.2 KEUR (30 September 2023) and 1,256.3 KEUR of short-term receivables (30 September 2023). (All figures are presented in accordance with IFRS and, unless otherwise stated, the comparison figures in brackets refer to the corresponding period in

Peab builds rental apartments in Malmö

Peab has been commissioned to build rental apartments in Malmö. The customer is MKB Fastighets AB and the contract is worth SEK 408 million.The new apartments will be built in Kirseberg in Malmö. The project consists of three buildings with a varying height of six to eight stories. All in all Peab will build 264 apartments and six other premises. “We’re proud to be able to contribute together with MKB to more homes for Malmö residents. This is a good example of our locally produced community building,” says Peter Lindstedt, Region Manager Peab. The project is a turnkey contract in

There are no items matching the current filter
There are no more items matching the current filter
Back to top